Previous 10 | Next 10 |
home / stock / flhlf / flhlf news
FILAMENT HEALTH ANNOUNCES TERMINATION OF SHAREHOLDER MEETING AND ENGAGEMENT OF DONOHOE ADVISORY FOR COMPLIANCE EXPERTISE Canada NewsWire VANCOUVER, BC , Dec. 18, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (" Filament " or t...
FILAMENT HEALTH ANNOUNCES ADJOURNMENT OF SPECIAL MEETING Canada NewsWire VANCOUVER, BC , Dec. 11, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (" Filament " or the " Company "), a clinical‐stage natural psychedel...
FILAMENT HEALTH FILES AMENDED PRO FORMA FINANCIAL STATEMENTS Canada NewsWire VANCOUVER, BC , Dec. 7, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (" Filament " or the " Company "), a clinical‐stage natural ps...
2023-12-06 11:26:25 ET More on Filament Health Filament Health signs term sheet for a $14.4M convertible note Historical earnings data for Filament Health Financial information for Filament Health For further details see: Filament Health raises $14.4M via...
FILAMENT HEALTH ANNOUNCES SIGNING OF DEFINITIVE AGREEMENT FOR CONVERTIBLE NOTE FINANCING, CLOSING OF C$900,000 NON-BROKERED PRIVATE PLACEMENT FINANCING, FOUNDER-LED NOTE OFFERING AND OTHER UPDATES RELATED TO UPCOMING SPECIAL MEETING AND PROPOSED BUSINESS COMBINATION Canada NewsWire ...
--News Direct-- Filament Health CEO Ben Lightburn joined Steve Darling from Proactive to announce the signing of a non-binding term sheet for potential funding of up to US$14.4 million. The funding is in collaboration with an affiliate of Helena Partners Inc., a Cayman-Islands-based advis...
2023-11-23 07:46:25 ET More on Filament Health Historical earnings data for Filament Health Financial information for Filament Health For further details see: Filament Health signs term sheet for a $14.4M convertible note
FILAMENT HEALTH SIGNS NON-BINDING TERM SHEET FOR CONVERTIBLE NOTE IN CONNECTION WITH PLANNED BUSINESS COMBINATION Canada NewsWire VANCOUVER, BC , Nov. 23, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company...
VANCOUVER, British Columbia, Nov. 15, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE:MDMA)(OTCQB:PMBHF), a Canadian biotechnology company dedicated to the research and development of clinical-grade LaNeo™ MDMA and novel MDXX compounds, and Filament ...
FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS Canada NewsWire VANCOUVER, BC , Nov. 14, 2023 /CNW/ - Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) ("Filament" or the "Company"), a clinical-stage natural ...
News, Short Squeeze, Breakout and More Instantly...
Vancouver, British Columbia--(Newsfile Corp. - June 14, 2024) - Negev Capital Fund One, L.P. (the " Acquiror "), a shareholder of Filament Health Corp. (" Filament "), announces that on June 12, 2024, it was issued 42,284,443 common shares of Filament (the " Common Shares ") from the conversion o...
FILAMENT HEALTH ANNOUNCES CLOSING OF WARRANT EXERCISE, NOTE CONVERSION AND CONCURRENT PRIVATE PLACEMENT OF COMMON SHARES Canada NewsWire VANCOUVER, BC , June 12, 2024 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) (" Filament " ...
FILAMENT HEALTH ANNOUNCES AUTHORIZATION OF PHASE 2 CLINICAL TRIAL FOR PEX010 IN THE TREATMENT OF METHAMPHETAMINE USE DISORDER Canada NewsWire Company study investigating PEX010, Filament's botanical psilocybin drug candidate, has been authorized by both FDA and Health Canada...